

GET OUR 2007 CATALOG
Latest News
About this new ARG Web Site
See us at these Conferences
Current Press Release
All Press Releases
Interview with Founder,
Stephen Levine
This site is intended for use only by healthcare professionals who utilize our products to nutritionally support their patients. Registered users may log-in at either Doctors or Patients.
|
You Are Here:
Home - October 2009 Focus Newsletter - The Age of Immunobiotics
October 2009 Focus Newsletter - The Age of Immunobiotics

Subscribe - it's free! |
Entire newsletter in
easily-printed PDF:

Click Here |
|
The Age of Immunobiotics
New Research Proves the Power of Friendly Bacteria for Infectious and Inflammatory Diseases
"Just one molecule can make the difference in modulating a healthy immune response. Surprisingly, it comes from bacteria." Thus begins an article in the August issue of The Scientist, written by microbiologist Sarkis Mazmanian of the California Institute of Technology. Summarizing his extraordinary work on a potential novel probiotic, B. fragilis, the biologist notes that "20 Nobel Prizes have been awarded for research on the immune response to harmful microbes. But in the grand scheme of things, bacterial infections are rare and opportunistic. Of the over 300,000 known bacterial species and possibly millions more, only about 170 are known to be pathogenic in mammals." In contrast, scientists are finally beginning to study and uncover the power of our friendly symbionts, the probiotics.
In this issue, we look at a completely novel approach to depression using probiotics. Pioneered by Dr. Michael Ash, it is the distillation of twenty years of research and work.
We also report on the two most-studied probiotics. Two stand out as immune-modulating powerhouses—both the subject of hundreds of scientific, peer-reviewed studies. These are Lactobacillus GG and Saccharomyces boulardii, and the weight of new evidence in the last few years shows both to be profound immunobiotics with an ability to promote health far beyond the digestive tract. Read further for the latest research on both.
This issue also offers guidance on administering probiotics. Probiotics work best when they are used in a staged, multi-step fashion that specifically addresses each individual’s needs (see A Novel Approach To Treating Depression).
The latest research shows that probiotics can protect against inflammation, arthritis, allergy, and infection. They shift immune response throughout the body. They are not just friendly bacteria. They are true immune modulators.
A Special Note from Stephen Levine, Ph.D.
Two Fresh Approaches to Chronic Illness and Inflammation
In this special issue we present landmark work by Martin Pall, Ph.D., and by Michael Ash, B.S.c. (Hons) D.O. N.D. F.Dip ION, who offer unique approaches to chronic inflammation. Their specific interventions are distinctly different and yet very complementary.
Both researchers understand that inflammation is at the core of illness. Both are tweaking the exact same immune and cytokine molecules and mediators. Both researchers address highly inflammatory regulatory immune molecules like NFKappaB and TNFα. What Dr. Pall has done is identify the key oxidative player that triggers many common “mystery illnesses”, from fibromyalgia to CFS to Gulf War Syndrome. What Dr. Ash has done is bring a profound new understanding to the role of gastrointestinal stress and offer novel approaches to treatment. These researchers have applied fundamental biological truths in unique ways to help us all.
Dr. Ash favors probiotics (with an emphasis on the two most widely researched and effective probiotics) to restore harmony and immune tolerance to the entire gut mucosal system, and thus reduce systemic inflammation. Dr. Pall uses specially formulated antioxidant food supplements to address excess levels of nitric oxide and its damaging metabolite, peroxynitrite. Yes, their approaches appear different, but their underlying models are consistent and harmonic. Not surprisingly, clinical evidence shows that both approaches yield impressive results. I see no reason not to apply both together.
For many years I’ve talked about chronic inflammation. Oxidative stress, which is ultimately electron imbalance leading to free radical damage; is the underpinning of much chronic inflammation. No matter the cause—environmental, physical or emotional trauma, infections, ionizing radiation, chemicals—all stress leads to chronic inflammation, and compromised immune function. This is a profound epiphany that I myself had over twenty-five years ago when I coauthored Antioxidant Adaptation with Parris Kidd, Ph.D.
|
|
Focus on Allergy Research Group
Editor-in-Chief: Stephen A. Levine, Ph.D.
Executive Editor: Jill Neimark
Medical Editor: Jeffrey L. Anderson, M.D.
Assistant Editors: Daniel Milosevich, CN, Diane Raile, CNC
Graphic Design & Layout: Christian Northcott |
| FOCUS publishes emerging nutritional science and scientific theories that should not be construed to be conclusive scientific proof of any specific cause, effect, or relationship. The publication is for the educational use of healthcare practitioners and physicians. The articles in the publication are the independent scientific views and theories of the authors. FOCUS takes no position on the views and theories expressed but offers them for candid inquiry and debate. The articles are not intended for use in support of the sale of any commercial product and should not be construed as indicative of the use or efficacy of any commercial product. Emerging science and scientific theories do not constitute scientific proof of any specific cause, effect, or relationship. |
Copyright © 2009 Allergy Research Group®.
Special permission is required to reproduce by any manner, in whole or in part, the materials herein contained. |
|